Loading clinical trials...

Study on the Priorities of Patients Admitted to Intensive Care | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

Study on the Priorities of Patients Admitted to Intensive Care

NCT07417592•University Hospital, Brest

Summary

The goal of this observational study is to learn about the priorities of patients admitted to intensive care units (ICUs) who have a life-threatening condition, as well as the priorities assumed by their designated relatives and healthcare professionals (nurses, nursing assistants, ICU physicians, and general practitioners).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult Patient
•Estimated length of stay in intensive care exceeding 72 hours
•No objection from the patient or the designated representative, if the patient is unable to consent to participate in the study
•Adult Person
•No objection to participate in the study
•No objection to participate in the study

Exclusion Criteria

•Patients under legal protection (guardianship, conservatorship)
•Pregnant or breastfeeding women
•Disagreement among the patient's relatives regarding the designated representative.

Locations (1)

CHU de Brest

Brest, France

Key Dates

Start Date

February 15, 2026

Primary Completion Date

August 15, 2027

Completion Date

November 14, 2027

Last Updated

March 5, 2026

Enrollment

100

ESTIMATED participants

Conditions

Intensive Care Unit Syndrome

Contacts

Thomas GARGADENNEC, MD

CONTACT

02 30 33 78 94 thomas.gargadennec@chu-brest.fr

Cerebral Perfusion Variation During Blood Pressure Changes in ICU

NCT05804773

Intensive Care Unit Syndrome

View study

RECRUITING

Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study

NCT06427265

Intensive Care Unit SyndromePrediction+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study on the Priorities of Patients Admitted to Intensive Care

Inclusion Criteria

Exclusion Criteria

Cerebral Perfusion Variation During Blood Pressure Changes in ICU

Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study

Delirium in Covid-19: Germany-wide Covid-19 Intensive Register

Feasibility, Acceptability, and Barriers to Implementation of a Geriatrics Bundle in the ICU

Impact on Family or Care-givers of Very Old ICU-survivors, Trajectories and 6 Months' Outcome in the Very Old.

Move to Music Video Intervention for ICU Survivors